Ossiam’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.7M | Sell |
50,502
-109,260
| -68% | -$23.5M | 0.17% | 93 |
|
|
2026
Q1 | $34.7M | Buy |
159,762
+98,852
| +162% | +$21.9M | 0.61% | 30 |
|
|
2025
Q4 | $13.9M | Buy |
60,910
+28,560
| +88% | +$6.51M | 0.28% | 53 |
|
|
2025
Q3 | $7.49M | Sell |
32,350
-246,449
| -88% | -$50.2M | 0.1% | 149 |
|
|
2025
Q2 | $51.8M | Buy |
278,799
+230,317
| +475% | +$42.8M | 0.58% | 33 |
|
|
2025
Q1 | $10.2M | Buy |
48,482
+9,075
| +23% | +$1.76M | 0.14% | 93 |
|
|
2024
Q4 | $7M | Sell |
39,407
-265,681
| -87% | -$48.8M | 0.12% | 116 |
|
|
2024
Q3 | $60.2M | Buy |
305,088
+246,716
| +423% | +$46M | 1.16% | 21 |
|
|
2024
Q2 | $10M | Sell |
58,372
-301
| -0.5% | -$49.9K | 0.19% | 76 |
|
|
2024
Q1 | $10.7M | Sell |
58,673
-531
| -0.9% | -$91.5K | 0.19% | 90 |
|
|
2023
Q4 | $9.17M | Buy |
59,204
+6,243
| +12% | +$910K | 0.15% | 95 |
|
|
2023
Q3 | $7.89M | Buy |
52,961
+17,934
| +51% | +$2.63M | 0.14% | 101 |
|
|
2023
Q2 | $4.72M | Sell |
35,027
-2,731
| -7% | -$400K | 0.08% | 136 |
|
|
2023
Q1 | $6.02M | Sell |
37,758
-3,124
| -8% | -$478K | 0.13% | 122 |
|
|
2022
Q4 | $6.61M | Sell |
40,882
-136,143
| -77% | -$20.9M | 0.17% | 98 |
|
|
2022
Q3 | $23.8M | Buy |
177,025
+19,885
| +13% | +$2.85M | 0.69% | 36 |
|
|
2022
Q2 | $24.1M | Sell |
157,140
-133,452
| -46% | -$20.4M | 0.72% | 37 |
|
|
2022
Q1 | $47.1M | Sell |
290,592
-71,779
| -20% | -$10.4M | 1.23% | 19 |
|
|
2021
Q4 | $49.1M | Buy |
362,371
+222,572
| +159% | +$26.3M | 1.29% | 19 |
|
|
2021
Q3 | $15.1M | Sell |
139,799
-10,526
| -7% | -$1.2M | 0.43% | 48 |
|
|
2021
Q2 | $17.5M | Sell |
150,325
-164,871
| -52% | -$18.6M | 0.47% | 50 |
|
|
2021
Q1 | $34.1M | Buy |
315,196
+202,136
| +179% | +$21.6M | 1.06% | 21 |
|
|
2020
Q4 | $12.1M | Sell |
113,060
-3,242
| -3% | -$312K | 0.42% | 56 |
|
|
2020
Q3 | $10.2M | Buy |
116,302
+82,665
| +246% | +$7.78M | 0.43% | 39 |
|
|
2020
Q2 | $3.3M | Buy |
33,637
+850
| +3% | +$74.8K | 0.21% | 93 |
|
|
2020
Q1 | $2.5M | Buy |
32,787
+30,845
| +1,588% | +$2.63M | 0.17% | 109 |
|
|
2019
Q4 | $172K | Sell |
1,942
-24,246
| -93% | -$2.01M | 0.01% | 325 |
|
|
2019
Q3 | $1.98M | Buy |
26,188
+25,114
| +2,338% | +$1.72M | 0.14% | 118 |
|
|
2019
Q2 | $78K | Buy |
+1,074
| New | +$84.4K | 0.01% | 391 |
|
|
2019
Q1 | – | Sell |
-7,505
| Closed | -$692K | – | 271 |
|
|
2018
Q4 | $692K | Buy |
+7,505
| New | +$660K | 0.1% | 128 |
|
Other funds holding ABBV
Ossiam's ABBV Position: Q2 2026 in Review
Ossiam reduced its AbbVie (ABBV) stake by 68% in Q2 2026, selling an estimated $23.5M and leaving 50,502 shares worth $12.7M. The position accounts for 0.17% of the portfolio, ranked #93.
Ossiam first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $60.2M in Q3 2024. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Ossiam held 50,502 shares of AbbVie worth $12.7M as of Q2 2026.
- Ossiam sold 109,260 AbbVie shares in Q2 2026, an estimated $23.5M.
- AbbVie made up 0.17% of Ossiam's portfolio in Q2 2026, its #93 holding.
- Ossiam first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
- Ossiam's AbbVie position peaked at $60.2M in Q3 2024.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.